Talk One: Factors Influencing Additional Nodal Disease and Pathologic Nodal Upstaging with Axillary Dissection in Patients with Residual Node-Positive Breast Cancer After Neoadjuvant Chemotherapy Enrolled on Alliance A011202 Clinical Trial
Presenter: Judy C. Boughey, MD

Talk Two: Quantitative Transmission Imaging Evaluation (QTIE Study)
Presenters: James Wiskin, PhD, MS with Jillian K. Kennedy, MD, Tiffany M. Sae-Kho, MD, and Christine U. Lee, MD, PhD

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to: 

• Recognize a new feasibility clinical trial that uses new ultrasound technology
• Recall evolution of 3D ultrasound tomography
• Discuss operational aspects of 3D ultrasound tomography
• Discuss potential applications and opportunities  

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.